Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature.
J Neuroimmunol
; 392: 578369, 2024 07 15.
Article
en En
| MEDLINE
| ID: mdl-38823118
ABSTRACT
Neuropsychiatric symptoms in N-methyl-d-aspartate receptor encephalitis (NMDARE) have led some to pursue empiric trials of electroconvulsive therapy (ECT). A scoping review identified 39 patients diagnosed with NMDARE undergoing ECT. Separately, a retrospective cohort was reviewed to characterize 21 patients. Clinical improvement was attributed to ECT in 49% of patients in the scoping review and 19% of patients in the retrospective cohort; timing of immunotherapies was a confounding factor. Worsening of clinical course following ECT was reported in 28% of patients in the scoping review and 38% of patient in the retrospective review. There is currently insufficient data supporting a beneficial effect of ECT in NMDARE.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Terapia Electroconvulsiva
/
Encefalitis Antirreceptor N-Metil-D-Aspartato
Idioma:
En
Revista:
J Neuroimmunol
Año:
2024
Tipo del documento:
Article